Andrea Van Beek Invites You to Join The 2025 Virtual Boot Camp
Andrea Van Beek, Board of Directors of Anticoagulation Forum, National Certification Board for Anticoagulation Providers, shared an inviing post on LinkedIn:
”Want to expand your knowledge about all-things anticoagulation – all from the comfort of your couch?!
Join us for our (very popular!) 2 day virtual Boot Camp this fall!
I’ll be giving talks about Warfarin day-to-day management (including some difficult warfarin cases), as well as Shared Decision Making and Patient Education.
You won’t want to miss our daily Chalk Talks – ask the experts all your burning questions.
Register today to reserve your spot!
The 2025 Virtual Boot Camp is now open for registration.
This trusted, expert-led program returns October 17–18 with fresh topics, real-world insights, and 30 days of enduring access to fit any schedule.”
Anticoagulation Forum shared a post on LinkedIn:
‘The 2025 Boot Camp offers:
Comprehensive curriculum covering anticoagulation, disease state, and drug management
Interactive “Chalk Talks” and live Q and As with expert faculty
Designed for pharmacists, physicians, nurses, and trainees
Earn valuable CE credits and practical strategies to bring back to your practice
The registration rate is USD349 for all registrants, and it will remain open until October 18, 2025. Group pricing is available; email [email protected] to inquire.
Whether you are training new clinicians or refreshing your own knowledge, this is a must-attend event for staying current and connected.’
Andrea Van Beek shared an invitation you should not miss. Register Now.
Learn about all the opportunities in the field with Hemostasis Today.
-
Aug 2, 2025, 18:28Filippo Crea Shares Some AI-Insights on Recurrent STEMI
-
Aug 2, 2025, 18:05MSK Cancer Center CME: Expert Insights on Benign Hematology, Hemostasis and Thrombosis
-
Aug 2, 2025, 17:56“Impressive Work!” – Flora Peyvandi on Laurence Zitvogel’s Recent Article
-
Aug 2, 2025, 17:44Understanding ESR: Dr. William Aird Breaks Down the Factors Behind Sedimentation Rate Changes
-
Aug 2, 2025, 17:34Oral Anticoagulation in VTE: Apixaban Safer and More Effective than Rivaroxaban or Warfarin
-
Aug 2, 2025, 18:53Acute Ischemic Minor Stroke and IV Thrombolysis: Findings from a Danish Nationwide Study
-
Aug 2, 2025, 04:31Acute VTE in Women: Continue Contraception, Select the Right Anticoagulant
-
Aug 1, 2025, 13:11Isabelle Mahé Shares an Insight from APICAT Study: Use of Apixaban in Cancer Associated Thrombosis
-
Jul 31, 2025, 16:12Samin Mohsenian Shares the Final Open Access Version: Ob/Gyn Complications and Congenital Fibrinogen Disorders
-
Jul 31, 2025, 15:45Tzu-Fei Wang: To Anticoagulate or Not To Anticoagulate—That Is The Question
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab
-
Jul 28, 2025, 12:53Zambia’s Hemophilia Prophylaxis Success
-
Jul 26, 2025, 16:14Cesar Garrido: Forging Strong Partnerships on WHA78 ''Global Health Equity'' Event
-
Jul 23, 2025, 15:34Don't Miss the Hemophilia B Virtual Event on July 29 – Sign Up Now!
-
Jul 23, 2025, 11:05Haemnet Gives Voice to Parents Facing the Challenges of Childhood Bleeding Disorders